Chicago Partners Investment Group LLC bought a new position in shares of Globe Life Inc. (NYSE:GL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,099 shares of the company's stock, valued at approximately $240,000.
A number of other large investors have also bought and sold shares of GL. Nuance Investments LLC boosted its holdings in shares of Globe Life by 155.6% in the 3rd quarter. Nuance Investments LLC now owns 1,138,978 shares of the company's stock valued at $120,629,000 after buying an additional 693,346 shares during the last quarter. Swedbank AB acquired a new stake in shares of Globe Life in the 4th quarter valued at approximately $52,414,000. International Assets Investment Management LLC boosted its holdings in shares of Globe Life by 15,398.7% in the 3rd quarter. International Assets Investment Management LLC now owns 336,631 shares of the company's stock valued at $356,530,000 after buying an additional 334,459 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Globe Life by 22.3% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,519,675 shares of the company's stock valued at $160,949,000 after buying an additional 277,108 shares during the last quarter. Finally, Segall Bryant & Hamill LLC boosted its holdings in shares of Globe Life by 78.5% in the 3rd quarter. Segall Bryant & Hamill LLC now owns 290,515 shares of the company's stock valued at $30,768,000 after buying an additional 127,764 shares during the last quarter. 81.61% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several equities research analysts have recently commented on the company. Morgan Stanley increased their price objective on Globe Life from $110.00 to $120.00 and gave the company an "equal weight" rating in a report on Thursday, October 24th. Evercore ISI upgraded Globe Life from an "in-line" rating to an "outperform" rating and increased their price target for the company from $132.00 to $143.00 in a research note on Wednesday, January 8th. Raymond James increased their price target on Globe Life from $160.00 to $188.00 and gave the company a "strong-buy" rating in a research note on Tuesday, October 15th. BMO Capital Markets began coverage on Globe Life in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $114.00 price target on the stock. Finally, Piper Sandler increased their price target on Globe Life from $118.00 to $130.00 and gave the company an "overweight" rating in a research note on Friday, October 25th. Five analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $132.18.
Get Our Latest Analysis on Globe Life
Globe Life Stock Performance
GL stock traded up $3.66 during trading hours on Friday, hitting $123.63. 958,110 shares of the stock were exchanged, compared to its average volume of 510,240. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $10.38 billion, a P/E ratio of 10.35 and a beta of 0.81. The company has a 50-day simple moving average of $113.19 and a two-hundred day simple moving average of $106.99. Globe Life Inc. has a 12 month low of $38.95 and a 12 month high of $132.00.
Globe Life (NYSE:GL - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, topping the consensus estimate of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. On average, analysts forecast that Globe Life Inc. will post 13.57 earnings per share for the current fiscal year.
Globe Life Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Monday, January 6th were given a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date of this dividend was Monday, January 6th. Globe Life's payout ratio is currently 8.03%.
Insider Buying and Selling
In related news, Director Mark A. Blinn sold 3,000 shares of the firm's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $113.23, for a total value of $339,690.00. Following the sale, the director now directly owns 5,122 shares of the company's stock, valued at $579,964.06. This trade represents a 36.94 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Frank M. Svoboda sold 14,340 shares of the firm's stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $108.80, for a total value of $1,560,192.00. Following the completion of the sale, the chief executive officer now directly owns 16,396 shares in the company, valued at $1,783,884.80. This trade represents a 46.66 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 39,788 shares of company stock worth $4,429,779. Company insiders own 1.51% of the company's stock.
Globe Life Company Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Recommended Stories

Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report